Skip to main content
SpringerLink
Log in

Effect ofd-fenfluramine on human experimental anxiety

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

To investigate the role of 5-HT in human anxiety, the 5-HT releaser and uptake blockerd-fenfluramine (FEN) was administered to healthy volunteers under two models of experimental anxiety. The first was a simulated public speaking (SPS) test consisting of talking in front of a video camera, anxiety being evaluated mainly by self-rating scales. The second was a conditioned fear test, in which the changes in skin electrical conductance caused by a tone associated once with an aversive white noise were measured. The doses of 15 and 30 mg FEN, PO, decreased anxiety induced by SPS in a dose-dependent way, as indicated by the anxiety factor of Norris Visual Analogue Mood Scale. In the conditioned fear test, however, the amplitude and level of skin conductance responses to the conditioned aversive stimulus were not significantly changed by FEN. The differential effects of FEN in these human experimental models of anxiety, together with similar results reported in rats, support the view that 5-HT exerts a dual action on brain mechanisms regulating anxiety, facilitating conditioned while inhibiting unconditioned fear. The presumed reduction in unconditioned fear caused by FEN may have implications for the treatment of panic disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian GK (1992) Central 5-HT receptor subtypes: physiological responses and signal transduction mechanisms. In: Marsden CA, Heal DJ (eds) Central serotonin receptors and psychotropic drugs. Blackwell, Oxford, pp 39–55

    Google Scholar 

  • Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101–103

    Google Scholar 

  • Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:240–245

    Google Scholar 

  • Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine,p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153–160

    Google Scholar 

  • Biaggio AMB, Natalício L, Spielberger CD (1976) The development and validation of an experimental Portuguese form of the state-trait anxiety inventory. In: Spielberger CD, Diaz-Guerrero R (eds) Cross-cultural research on anxiety. Hemisphere/Wiley, Washington DC, p 29

    Google Scholar 

  • Blier P, de Montigny C, Chaput Y (1987) Modification of the serotonin system by the antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S

    Google Scholar 

  • Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218

    Google Scholar 

  • Bonnano G, Fassio A, Severi P. Ruelle A, Raiteri M (1994) Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J Neurochem 63:1163–1166

    Google Scholar 

  • Celeumans DLS, Hoppenbrouwers MLJA, Gelders YG, Reynjens AHM (1982) The influence of ritanserin, a serotonin antagonist in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303–305

    Google Scholar 

  • Deakin JWF, Graeff FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5:305–315

    Google Scholar 

  • Deakin JFW, Graeff FG, Guimarães FS (1992) 5-HT receptor subtypes and the modulation of aversion. In: Marsden CA, Heal DJ (eds) Central serotonin receptors and psychotropic drugs. Blackwell, Oxford, pp 147–174

    Google Scholar 

  • Deakin JFW, Guimarães FS, Graeff GF (1994) Testing 5HT theories of anxiety in normal volunteers. In: Palomo T, Archer T (eds) Strategies for studying brain disorders, vol. 1. Farrand Press, London, pp 211–238

    Google Scholar 

  • Den Boer JA, Westenberg HGM (1990) Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102:85–94

    Google Scholar 

  • Fuller RW, Snoddy HD, Robertson DW (1988) Mechanisms of effects ofd-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol Biochem Behav 30:715–721

    Google Scholar 

  • Graeff FG (1990) Brain defense systems and anxiety. In: Roth M, Burrows GD, Noyes R (eds) Handbook of anxiety vol 3: the neurobiology of anxiety. Elsevier, Amsterdam, pp 307–354

    Google Scholar 

  • Graeff FG (1993) Role of 5-HT in defensive behavior and anxiety. Rev Neurosci 4:181–211

    Google Scholar 

  • Graeff FG, Zuardi AW, Giglio JS, Lima Filho EC, Kamiol IG (1985) Effect of methergoline on human anxiety. Psychopharmacology 86:334–336

    Google Scholar 

  • Graeff FG, Viana MB, Tomaz CAB (1993a) The elevated T-maze, a new experimental model of anxiety and memory: effect of diazepam. Braz J Med Biol Res 26:67–70

    Google Scholar 

  • Graeff FG, Silveira MCL, Nogueira RL, Audi EA, de Oliveira RMW (1993b) Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 58:123–131

    Google Scholar 

  • Graeff FG, Viana MB, Mora PO (1995) Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T maze. Pharmacol Biochem Behav 53:171–177

    Google Scholar 

  • Guimarães FS, Zuardi AW, Graeff FG (1987) Effect of chlorimipramine and maprotiline on experimental anxiety in humans. J Psychopharmacol 1:184–192

    Google Scholar 

  • Guimarães FS, Kohem CL, Fillmann HS, de Vecino MCA, de Paoli CL, Ribeiro AMS, Teixeira CC, Wannmacher L (1989) A simple simulated public speaking test for evaluation of anxiolytic drugs. Braz J Med Biol Res 22:1083–1089

    Google Scholar 

  • Guimarães FS, Hellewell J, Hensman R, Wang M, Deakin JFW (1991) Characterisation of a psychophysiological model of classical fear conditioning in healthy volunteers: Influence of gender, instructions, personality and placebo. Psychopharmacology 104:231–236

    Google Scholar 

  • Handley SL, McBlane JW (1993) 5HT drugs in animal models of anxiety. Psychopharmacology 112:13–20

    Google Scholar 

  • Hensman R, Guimaräes FS, Wang M, Deakin JFW (1991) The effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology 104:220–224

    Google Scholar 

  • Hetem LAB (1995) Addition ofd-fenfluramine to benzodiazepines produced a marked improvement in refractory panic disorder — a case report. J Clin Psychopharmacol 16:77–78

    Google Scholar 

  • Humble M, Aberg-Wistedt B, Bertilson L (1986) A pilot study of ritanserin (a selective serotonin-2 receptor antagonist) in panic disorder and agoraphobia. Clinical and biochemical effects. Abstracts of the 15th CINP Congress, p 165

  • Jensen HH, Hutchings B, Poulsen JC (1989) Conditioned emotional responding under diazepam; a psychological study of state depending learning. Psychopharmacology 98:392–397

    Google Scholar 

  • Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208

    Google Scholar 

  • McCann U, Hatzdimitriou G, Ridenour A, Fisher C, Yuan J, Katz J, Ricaurte G (1994) Dexfenfluramine and serotonin toxicity: further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 268:792–798

    Google Scholar 

  • McNair DM, Frankenthaler LM, Czerlinsky T, White TW, Sasson S, Fischer S (1982) Simulated public speaking as a model of clinical anxiety. Psychopharmacology 77:7–10

    Google Scholar 

  • McTavish D, Heel RC (1992) Dexfenfluramine: a review of its pharmacological properties and therapeutic potential in obesity. Drugs 43:713–733

    Google Scholar 

  • Norris H (1971) The action of sedatives on brainstem oculomotor systems in man. Neuropharmacology 10:181–191

    Google Scholar 

  • Nutt DJ (1991) Anxiety and its therapy: today and tomorrow. In: Briley M, File SE (eds) New concepts in anxiety. Macmillan Press, London, pp 1–2

    Google Scholar 

  • Palma SM, Guimarães FS, Zuardi AW (1994) Anxiety induced by simulated public speaking and stroop color word test in healthy subjects: effects of different trait-anxiety levels. Braz J Med Biol Res 27:2895–2902

    Google Scholar 

  • Puttkammer Von M, Gaertner HJ, Mahal A, May J, Binz U, Heimann H (1987) Zur anxiolytishen Wirkung eines Phenoxypropanolamin-Derivates im Vergleich zu Propranolol, Diazepam und Plazebo. Drug Res 37:721–725

    Google Scholar 

  • Sheehan DV, Raj AB, Sheehan KH, Soto S (1990) Is buspirone effective in the treatment of panic disorder? J Clin Psychopharmacol 10:3–11

    Google Scholar 

  • Solyom L (1994) Controlling panic attacks with fenfluramine. Am J Psychiatry 151:621–622

    Google Scholar 

  • Spielberger CD, Gorsuch RI, Lushene RE (1970) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo, Alto, California, USA

    Google Scholar 

  • Targum SD (1990) Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry 28:2–34

    Google Scholar 

  • Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28:295–306

    Google Scholar 

  • Venables PH, Christie MJ (1980) Electrodermal activity. In: Martin I, Venables PH (eds) Techniques in psychophysiology. Wiley, Chichester pp 3–67

    Google Scholar 

  • Viana MB, Tomaz C, Graeff FG (1994) The elevated T maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49:549–554

    Google Scholar 

  • Wise CD, Berger BD, Stein L (1972) Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177:180–183

    Google Scholar 

  • Zuardi AW, Karniol IG (1981) Estudo transcultural de uma escala de auto-avaliação para estados subjectivos. J Bras Psiq 131:403–406

    Google Scholar 

  • Zuardi AW, Cosme RA, Graeff FG, Guimarães FS (1993) Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 7:62–88

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Neurologia, Psiquiatria e Psicologia Médica, Universidade de São Paulo, 14049-900, Ribeirão Preto, SP, Brazil

    L. A. B. Hetem, C. J. de Souza & A. W. Zuardi

  2. Departamento de Farmacologia, FMRP, Universidade de São Paulo, 14049-900, Ribeirão Preto, SP, Brazil

    F. S. Guimarães

  3. Laboratorio de Psicofarmacologia, FFCLRP e Núcleo de Neurociências e Comportamento, Universidade de São Paulo, 14040-901, Ribeirão Preto, SP, Brazil

    F. G. Graeff

Authors
  1. L. A. B. Hetem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. J. de Souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. W. Zuardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. S. Guimarães
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. G. Graeff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hetem, L.A.B., de Souza, C.J., Zuardi, A.W. et al. Effect ofd-fenfluramine on human experimental anxiety. Psychopharmacology 127, 276–282 (1996). https://doi.org/10.1007/BF02246136

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246136

Key words

Search

Navigation